President Trump’s campaign promises of lower taxes and relaxed regulations were initially well-received by investors and business leaders, who believed he would prioritize those policies over more disruptive ones like tariffs. However, Trump’s focus on tariffs and subsidy cuts has caused uncertainty in the economy, leading to market volatility and decreased confidence among consumers and businesses. Despite warnings of economic damage, Trump remains undeterred, emphasizing the need for a “period of transition” and defending his policies as necessary for long-term economic health.
Full Article
Bicycle (BCYC) Q2 Revenue Falls 69%
Bicycle Therapeutics Plc (NASDAQ:BCYC) reported Q2 2025 GAAP revenue of $2.9 million, significantly below the $9.43 million analyst estimate, while net loss per share widened to $(1.14), surpassing the $(0.95) forecast. Despite increased clinical investment and operational spending aimed at advancing its pipeline of precision-guided therapeutics using its proprietary Bicycle molecule platform, the company emphasized the need for operational discipline and clear milestones ahead. Want More Context? 🔎
Read more